Shut Down

CardioDx Stock

CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.

Sign up today and learn more about CardioDx Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About CardioDx Stock

CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.

Funding History

July 2006$19.0M
May 2010$34.5M
May 2011$60.0M
August 2011$8.0M
July 2012$30.5M
August 2012$58.0M
July 2014$21.0M
December 2014$35.0M
June 2016$12.4M
January 2017$22.5M


VP, Development

Susan Daniels

Vice President, Technical Operations

Brian Rhees

Chief Commercial Officer

Deborah Kilpatrick

Chief Medical Officer

Mark Monane

Team Member

Anzhelika Rogacheva

Chief Financial Officer

Timothy Henn

Fellow, Head of Research

James Wingrove

Founder & Chief Strategy Officer

David Levison

Vice President, Sales and Marketing

Duane Williams

President and CEO

Khush Mehta

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: